Yahoo Finance BioTime, Inc. (BTX) Looks Good: Stock Adds 6% in Session
BioTime, Inc. BTX was a big mover last session, as the company saw its shares rise 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading within a volatile range of $2.57–$2.85 in the past one-month time frame, showed a sharp increase yesterday.
The company has not seen any estimate revisions over the past one month, while the Zacks Consensus Estimate for the current quarter also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
BioTime currently has a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.
BioTime, Inc. Price
BioTime, Inc. Price | BioTime, Inc. Quote
A better-ranked stock in the Medical - Biomedical and Genetics industry is Protagonist Therapeutics, Inc. PTGX, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is BTX going up? Or down? Predict to see what others think: Up or Down
Breaking News: Cryptocurrencies Now Bigger than Visa
The total market cap of all cryptos recently surpassed $700 billion – more than a 3,800% increase in the previous 12 months. They’re now bigger than Morgan Stanley, Goldman Sachs and even Visa! The new asset class may expand even more rapidly in 2018 as new investors continue pouring in and Wall Street becomes increasingly involved.
Zacks’ has just named 4 companies that enable investors to take advantage of the explosive growth of cryptocurrencies via the stock market.
Click here to access these stocks. >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BioTime, Inc. (BTX) : Free Stock Analysis Report
Protagonist Therapeutics, Inc. (PTGX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
